Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients

Čap, P.; Chládek, J.; Pehal, F.; Marý, M.; Petr&udot;, V.; Barnes, P. J.; Montuschi, P.
June 2004
Thorax;Jun2004, Vol. 59 Issue 6, p465
Academic Journal
Background: Leukotriene-like immunoreactivity has been detected in exhaled breath condensate (EBC), but definitive evidence for the presence of leukotrienes (LTs) in this biological fluid is not available. A study was undertaken to determine whether LTC4, LTD4, LTE4, and LTB4 are measurable in EBC by gas chromatography/mass spectrometry and to quantify exhaled LTs in adults and children with asthma and in control subjects. Methods: Twenty eight adults and 33 children with mild to moderate persistent asthma treated with inhaled corticosteroids and age matched healthy controls (50 adults and 50 children) were studied. LTB4, LTC4, LTD4, and LTE4 in EBC were measured by gas chromatography/mass spectrometry. Results: LTD4, LTE4, and LTB4 were detectable in all samples. Concentrations of LTC4 in EBC were either close to or below the detection limit of 1 pg/ml. Median exhaled LTD4, LTE4, and LTB4 concentrations in asthmatic adults were increased 4.1 -fold (p<0.001), 1.8-fold (p<0.01), and 2.6-fold (p<0.001), respectively, compared with values in healthy adults. Median exhaled LTD4, LTE4, and LTB4 concentrations in asthmatic children were increased 2.8-fold (p<0.001), 1.3-fold (p<0.001), and 1.6-fold (p<0.001), respectively, compared with those in healthy children. In patients with asthma there was a correlation between exhaled LTD4 and LTE4 in both adults (r=0.87, p<0.0001) and children (r=0.78, p<0.000l). Conclusions: Gas chromatography/mass spectrometry can be used to accurately quantify exhaled LTs which are increased in asthmatic adults and children compared with controls.


Related Articles

  • Daclizumab: A Potential Asthma Therapy? Antoniu, Sabina A. // Recent Patents on Inflammation & Allergy Drug Discovery;Nov2010, Vol. 4 Issue 3, p214 

    Airways inflammation in asthma is triggered and maintained by CD4+ (Th2) cells which are activated by IL-2 and stimulate the eosinophilic inflammation, IgE secretion and mucus hyperproduction. Current anti-inflammatory therapies include inhaled corticosteroids, and leukotriene modifiers but they...

  • NEW ORAL THERAPY FOR CHILDHOOD ASTHMA. Breznay, Jennifer B.; Ellsworth, Allan // Journal of Family Practice;Jul1998, Vol. 47 Issue 1, p15 

    The article discusses research being done on new oral therapy for childhood asthma. Consensus guidelines for treating moderate asthma are outlined elsewhere. The role of the other leukotriene inhibitors is not well defined in these guidelines. This 8-week study provides surrogate data that...

  • Changes in recommended treatments for mild and moderate asthma. Redding, Gregory J.; Stoloff, Stuart W. // Journal of Family Practice;Sep2004, Vol. 53 Issue 9, p692 

    This article reviews the 2002 National Asthma Education and Prevention Program (NAEPP) recommendations for the use of controlled medications for asthma, including the relative effectiveness of inhaled corticosteroids (ICSs) versus other controller medications, safety of long-term ICS use in...

  • What best prevents exercise-induced bronchoconstriction for a child with asthma? Preston, Jeffrey; Cucuzzella, Mark; Jamieson, Barbara // Journal of Family Practice;Jul2006, Vol. 55 Issue 7, p631 

    The article provides information regarding the effective ways in preventing exercise-induced bronchoconstriction for a child with asthma. Inhaled short-acting beta-agonists are considered to be the most effective way in preventing exercise-induced bronchoconstriction, followed by inhaled mast...

  • Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild asthma. Skoner, David P.; Gentile, Deborah A.; Angelini, Betty // Allergy & Asthma Proceedings;Jan/Feb2010, Vol. 31 Issue 1, p10 

    Corticosteroids are the foundation of pharmacologic treatment for children with asthma. However, high-dose inhaled corticosteroid treatment can cause hypothalamic-pituitary-adrenal (HPA) axis suppression. We investigated the effect of three doses of mometasone furoate administered via dry-powder...

  • Magnesium and Outcomes in Children with Acute Asthma. Sadovsky, Richard // American Family Physician;6/15/2001, Vol. 63 Issue 12, p2441 

    Presents information on a study by R.J. Scarfone and others that studied the early administration of magnesium to moderately to severely ill children with asthma in a randomized, double-blind, placebo-controlled clinical trial. Description of the study and its results; Conclusion that among a...

  • ASTHMA.  // Thorax;Dec2001 Supp, Vol. 56, piii72 

    This article presents various studies related to asthma. It is well known that anatomical dead space increases with end-inspiratory lung volume. The gradient of the relationship is regarded as an index of airway distensibility. Between 1-10% of patients on ACEI require discontinuation of therapy...

  • Evaluation of Theophylline or Pranlukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, as Add-On Therapy in Uncontrolled Asthmatic Patients with a Medium Dose of Inhaled Corticosteroids. Tsuchida, Tomoko; Matsuse, Hiroto; Machida, Ikuko; Kondo, Yuki; Saeki, Sachiko; Tomari, Shinya; Obase, Yasushi; Matsuo, Nobuko; Shimoda, Terufumi; Kohno, Shigeru // Allergy & Asthma Proceedings;Jul/Aug2005, Vol. 26 Issue 4, p287 

    A few studies compared the additional effects of oral controller medicines on pulmonary function in asthmatic patients on a moderate dose of inhaled steroids. The aim of this study was to compare the additional effects of two oral asthma controllers, a leukotriene receptor antagonist and a...

  • Review: Leukotriene-receptor antagonists are less effective than intranasal corticosteroids for allergic rhinitis. Li, James T. // ACP Journal Club;Sep/Oct2004, Vol. 141 Issue 2, p45 

    This article investigates that leukotriene receptor antagonists are less effective than antinasal corticosteroids for allergic rhinitis. In patients with allergic rhinitis, leukotrienereceptor antagonists did not differ from anti-histamines and were less effective than intranasal steroids in...


Read the Article


Sign out of this library

Other Topics